NT2025
 

Online Registration

News Released

Speaking Proposals Are Now Being Accepted
Call for Exhibitors and Sponsors
Call for Media Partners and Journal Cooperation

Abstract Format Download

Hosting Organization


World High Tech Society

Supporting Organization


International Society for Medical Laser Applications


American Society of Laser Acupuncture Therapy

Media Partners

Scientific Program



The 15th Annual World Congress of

Neurotalk-2025

Time: October 15-17, 2025

Venue: Crowne Plaza Nice - Grand Arenas, France

 

Notice: Please note this is not the final programs and it will be some changes due to the speakers’ schedule, it better to book your trip from October 15-17 before the final programs update on August 15, 2025

 

Keynote Forum

Time: 09:10-11:50, October 15 (Wednesday), 2025

Moderator

Call for Moderator

Time

Speeches and Speakers

09:10-09:15

Moderator’s Introduction

09:15-09:35

Speech Opportunity Available

09:35-09:55

Speech Opportunity Available

 

 

Track 1: Frontiers in Neuroscience

Session 1-1: Neurogenetics and Neurogenomics

Session 1-2: Cognitive and Behavior Neuroscience

Session 1-3: Neuroplasticity and Learning

Session 1-4: Connectomics

Session 1-5: Glia-Neuron Interactions

Session 1-6: Neuroimmunology and Neuroinflammation

Session 1-7: Neural Circuits and Systems Neuroscience

Session 1-8: Neuropharmacology and Neurochemistry

Session 1-9: Biology of Aging and Neurogenesis

Session 1-10: Computational Neuroscience

Session 1-11: Neural Stem Cells and Neuroregeneration

Session 1-12: Quantum Neuroscience

Time: 13:30-17:30, October 15 (Wednesday), 2025

Chair

Dr. Barbara Di Benedetto, Group Leader, University Clinic of Regensburg, Germany

Co- Chair

Dr. Catherine M. Cahill, Assistant Professor, Harvard Medical School, USA

13:30-13:35

Chairman's Introduction

13:35-14:00

Title: High Glucose Modulation of TGFβ1-Smad Pathway in Primary Human Macrophages: Diabetes and Vascular Complications

Dr. Kareem Awad, Professor, Ruprecht-Karls-University of Heidelberg, Germany

14:00-14:25

Title: Astrocyte-Dependent Synaptic Phagocytosis in Health and Major Depressive Disorder

Dr. Barbara Di Benedetto, Group Leader, University Clinic of Regensburg, Germany

14:25-14:50

Title: TBD

Dr. Lirong Zheng, Distinguished Professor and Dean, Fudan University, China

14:50-15:15 

Title: An Innovative Smart and Sustainable Low-Cost Irrigation System for Anomaly Detection Using Deep Learning

Dr. Amine Dahane, Assistant Professor, University of Oran 1, Algeria

15:15-15:30

Coffee Break

15:30-15:55

Title: TBD

Dr. Catherine M. Cahill, Assistant Professor, Harvard Medical School, USA

15:55-16:20

Title: Anesthesia and Apoptosis in Developing Brain

Dr. Dario Galante, Director, Department of Aneshtesia and Intensive Care Hospital G. Tatarella, Italy

16:20-16:45

Title: TBD

Dr. Natasa Petronijevic, Professor, University of Belgrade, Serbia

16:45-17:10

Speech Opportunity Available

 

Session 1-2: Cognitive and Behavior Neuroscience

Time: 08:30-12:10, October 16 (Thursday), 2025

Chair

Dr. Sheila G. Crewther, Professor, La Trobe University, Australia

Co- Chair

Call for Co-Chair

08:30-08:35

Chairman's Introduction

08:35-09:00

Title: TBD

Dr. Manuel Rodrigues, Professor, Polytechnic of Porto, Portugal

09:00-09:25

Title: TBD

Dr. Susanna Bianchini, Professor, Institute for Research on Intrapsychic and Relational Processes, Italy

09:25-09:50

Title: TBD

Dr. David Gold, Managing Director, Gold-Knecht Associates, Switzerland

09:50-10:15 

Speech Opportunity Available

08:30-08:35

Coffee Break

 

Track 2: Advanced Neurotechnologies

Session 2-1: Brain-Machine Interfaces

Session 2-2: Optogenetics

Session 2-3: Neuroimaging

Session 2-4: Neuromodulation Technologies

Session 2-5: Neurotechnology and Wearable Devices

Session 2-6: CRISPR and Gene Editing

Session 2-7: Organoids and Brain-on-a-Chip

Session 2-8: Neurophotonics

Session 2-9: Single-Cell Transcriptomics

Session 2-10: New Neurosurgery Technologies

Time: 13:30-17:30, October 16 (Thursday), 2025

Chair

Dr. Kevin D. Plancher, Clinical Professor, Albert Einstein College of Medicine, USA

Co- Chair

Dr. Pasquale Arpaia, Professor, Università di Napoli Federico II, Italy

13:30-13:35

Chairman's Introduction

13:35-14:00

Title: Machine Learning Methods and Applications in Finance

Dr. Yongzeng Lai, Professor, Wilfrid Laurier University, Canada

14:00-14:25

Title: TBD

Dr. Kevin D. Plancher, Clinical Professor, Albert Einstein College of Medicine, USA

14:25-14:50

Title: TBD

Dr. Christian Sandor, Professor, Université Paris-Saclay / Centre National de la Recherche Scientifique, France

14:50-15:15 

Title: Pompe Disease: How do We Diagnose?

Dr. Jorge Sales Marques, Center of Diagnosis and Evaluation of Rare disorders, Hospital Cuf Porto, Portugal

15:15-15:30

Coffee Break

15:30-15:55

Title: Daily Wearable Brain Computer Interfaces: After Data are We Loosing also Thoughts Privacy?

Dr. Pasquale Arpaia, Professor, Università di Napoli Federico II, Italy

15:55-16:20

Title: Bitcoin Transaction Computational Efficiency and Network Node Power Consumption Prediction Using an Artificial Neural Network

Dr. Arcel Kalenga Muteba, University of Johannesburg, South Africa

16:20-16:45

Title: Design and Characterization of An Emulsion Enriched with Essential Oils and Natural Compounds: Assessment of Stability, Exploration of Biological Properties, and Molecular Modeling Analysis

Dr. Djamel Atsamnia, Yahia Fares University, Algeria

16:45-17:10

Speech Opportunity Available

 

Track 3: Clinical Neurology and Neurorehabilitation

Session 3-1: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease and Dementia

Session 3-2: Amyotrophic Lateral Sclerosis and Multiple Sclerosis

Session 3-3: Epilepsy

Session 3-4: Stroke and Cerebrovascular Diseases

Session 3-5: Neuro Oncology and Brain Tumors

Session 3-6: Bipolar Disorders, Schizophrenia & Mental Disorders

Session 3-7: Depression, Anxiety, Autism and Stress Management

Session 3-8: Traumatic Brain Injury

Session 3-9: Sleep Disorders

Session 3-10: Neuroinfectious Diseases

Session 3-11: Headache Disorders

Session 3-12: Neuroophthalmology

Session 3-13: Peripheral Neuropathy

Session 3-14: Pediatric Neurology

Session 3-15: Neuroimmunotherapy

Session 3-16: Cell and Gene Therapy for Neurodegenerative Diseases

Session 3-17: Personalized Medicine for Brain Disorder

Session 3-18: Neurorehabilitation

Time: 08:30-12:10, October 17 (Friday), 2025

Chair

Call for Chair

Co- Chair

Dr. Thomas F. Feiner, Professor, Institute for EEG-Neurofeedback, Germany

08:30-08:35

Chairman's Introduction

08:35-09:00

Title: What is the Meaning of Empathy and Resilience in People with SCI

Dr. Monika Zackova, Professor, Montecatone Rehabilitation Institute, Italy

09:00-09:25

   Speech Opportunity Available

09:25-09:50

Title: Taking Care of Aging from Birth

Dr. Ascensión Marcos, Professor, Spanish National Research Council, Spain

09:50-10:15 

Title: What is New in NEURO

Dr. Manuela A. Aschauer, Assistant Professor, Medical University of Graz, Austria

10:15-10:30

Coffee Break

10:30-10:55

Title: TBD

Dr. Thomas F. Feiner, Professor, Institute for EEG-Neurofeedback, Germany

10:55-11:20

Title: Attention Measurement of an Autism Spectrum Disorder User Using EEG Signals: A Case Study

Dr. José Jaime Esqueda-Elizondo, Universidad Autónoma de Baja California, Mexico

11:20-11:45

Title: Vincristine-Induced Neuropathy: Exploring the Impact of Dose Rounding in Oncology Patients

Dr. Noura N. Aljabali, King Saud University, Saudi Arabia

11:45-12:10

Speech Opportunity Available

 

Session 3-1: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease and Dementia

Time: 08:30-12:10, October 17 (Friday), 2025

Chair

Dr. Istvan J. E. Boksay, Clinical Professor, New York University, USA

Co- Chair

Dr. Eef Hogervorst, Professor, Loughborough University, UK

13:30-13:35

Chairman's Introduction

13:35-14:00

Title: New Potential Developments in Alzheimer’s Disease Therapies

Dr. Jeffrey T. Apter, President, Global Clinical Trials LLC, USA

14:00-14:25

Title: Dementia Prevention; The Effect of Medical Conditions on Cognitive Decline

Dr. Istvan J. E. Boksay, Clinical Professor, New York University, USA

14:25-14:50

Title: Memtin for Alzheimer's: Propelling Into The Future, Personalized Medicine

Dr. Nikolaos Tezapsidis, CEO, Neurotez Inc., USA

14:50-15:15 

Title: A New Very Early Blood Test Diagnostics for Parkinson’s Disease

Dr. Hermona Soreq, Professor, The Edmond and Lily Safra Center for Brain Sciences, Israel

15:15-15:30

Coffee Break

15:30-15:55

Title: The Dulling of the Senses as An Early Indicator of Alzheimer’s Disease

Dr. Eef Hogervorst, Professor, Loughborough University, UK

15:55-16:20

Title: TBD

Dr. Harry W.M.Steinbusch, Professor, Maastricht University, The Netherlands

16:20-16:45

Title: Non-Invasive Biomarkers I in Dementias 

Dr. Manuela G. Neuman, Professor, University of Toronto, Canada

16:45-17:10

Speech Opportunity Available

 

Video Forum

Time: 08:30-18:30, June 18-20, 2025

1

Speech Opportunity Available

2

Speech Opportunity Available

3

Speech Opportunity Available

 

 

Hosting Organization

Foreign Experts Databank of SAFEA (Dalian Branch)

Abstract Format Download

 

Contact Us

3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road, Hi-tech Industrial Zone, Dalian City, Liaoning Province, China

Tel: 0086-411-84799609

Copyright © 2003-2025 BIT Congress Inc